Anthropic says automated attack surface analysis and reduction can meaningfully improve deployed software security in the near term, and previews data from applying it to large open-source codebases.
OpenAI says the deal would bring AI-powered operations to life sciences R&D, helping biopharma teams speed up drug development and advance new treatments.
Anthropic asked an internal research Claude model to design minibinders, small proteins that attach tightly to a target, as a test of protein design against neurotoxins.
OpenAI says it is improving ChatGPT across low-resource programming languages and introduces new evaluations covering software engineering, SQLite and COBOL migration.